Xencor, Inc. (XNCR)
26.08
-2.80
(-9.71%)
USD |
NASDAQ |
Aug 28, 16:00
26.05
-0.02
(-0.10%)
After-Hours: 18:32
Xencor Total Liabilities (Quarterly) : 221.73M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 221.73M |
| March 31, 2026 | 221.21M |
| December 31, 2025 | 239.91M |
| September 30, 2025 | 243.50M |
| June 30, 2025 | 259.07M |
| March 31, 2025 | 264.82M |
| December 31, 2024 | 277.92M |
| September 30, 2024 | 293.98M |
| June 30, 2024 | 291.90M |
| March 31, 2024 | 297.12M |
| December 31, 2023 | 303.05M |
| September 30, 2023 | 109.42M |
| June 30, 2023 | 99.24M |
| March 31, 2023 | 119.83M |
| December 31, 2022 | 118.77M |
| September 30, 2022 | 112.57M |
| June 30, 2022 | 108.98M |
| March 31, 2022 | 94.90M |
| December 31, 2021 | 104.71M |
| September 30, 2021 | 78.40M |
| June 30, 2021 | 48.66M |
| March 31, 2021 | 109.12M |
| December 31, 2020 | 130.80M |
| September 30, 2020 | 77.87M |
| June 30, 2020 | 74.08M |
| Date | Value |
|---|---|
| March 31, 2020 | 73.96M |
| December 31, 2019 | 77.05M |
| September 30, 2019 | 76.01M |
| June 30, 2019 | 76.66M |
| March 31, 2019 | 87.44M |
| December 31, 2018 | 55.05M |
| September 30, 2018 | 53.31M |
| June 30, 2018 | 72.28M |
| March 31, 2018 | 74.61M |
| December 31, 2017 | 73.74M |
| September 30, 2017 | 107.72M |
| June 30, 2017 | 114.80M |
| March 31, 2017 | 114.56M |
| December 31, 2016 | 114.61M |
| September 30, 2016 | 119.71M |
| June 30, 2016 | 125.68M |
| March 31, 2016 | 35.15M |
| December 31, 2015 | 44.48M |
| September 30, 2015 | 58.17M |
| June 30, 2015 | 10.50M |
| March 31, 2015 | 9.337M |
| December 31, 2014 | 8.533M |
| September 30, 2014 | 11.16M |
| June 30, 2014 | 10.85M |
| March 31, 2014 | 12.43M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Incyte Corp. | 1.528B |
| Regeneron Pharmaceuticals, Inc. | 10.02B |
| MacroGenics, Inc. | 302.54M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 724.96M |
| Shareholders Equity (Quarterly) | 503.23M |
| Debt to Equity Ratio | 0.338 |
| Current Ratio | 6.391 |
| Net Debt Paydown Yield | 0.87% |